Belite Bio (BLTE) Institutional Ownership $65.94 +0.74 (+1.14%) As of 10:46 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Belite Bio (NASDAQ:BLTE)CurrentInstitutional OwnershipPercentage0.53%Number ofInstitutional Buyers(last 12 months)10TotalInstitutional Inflows(last 12 months)$16.42MNumber ofInstitutional Sellers(last 12 months)8TotalInstitutional Outflows(last 12 months)$814.65K Get BLTE Insider Trade Alerts Want to know when executives and insiders are buying or selling Belite Bio stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data BLTE Institutional Buying and Selling by Quarter Belite Bio Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails8/15/2025 BNP Paribas Financial Markets3,291$190K0.0%N/A0.010% 8/15/2025 Bank of America Corp DE914$53K0.0%-82.5%0.003% 8/13/2025 Marshall Wace LLP9,486$547K0.0%N/A0.030% 8/13/2025 EverSource Wealth Advisors LLC2,550$147K0.0%N/A0.008% 8/13/2025 Virtus Investment Advisers LLC1,513$87K0.0%-41.6%0.005% 8/12/2025 JPMorgan Chase & Co.6,757$390K0.0%-17.2%0.021% 7/14/2025 GAMMA Investing LLC1,582$91K0.0%-14.4%0.005% 5/16/2025 Alyeska Investment Group L.P.83,623$5.54M0.0%N/A0.263% 4/15/2025 GAMMA Investing LLC1,849$122K0.0%+43.3%0.006% 4/7/2025 GAMMA Investing LLC122,441$8.11M0.0%+9,391.6%0.385% Get the Latest News and Ratings for BLTE and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Belite Bio and its competitors with MarketBeat's FREE daily newsletter. 2/17/2025 Citadel Advisors LLC5,211$329K0.0%-19.3%0.017% 2/17/2025 Bank of America Corp DE18,342$1.16M0.0%+36.4%0.059% 2/17/2025 BNP Paribas Financial Markets2,450$155K0.0%N/A0.008% 2/14/2025 Virtus ETF Advisers LLC1,122$71K0.0%-39.1%0.004% 2/13/2025 Marshall Wace LLP5,865$370K0.0%-30.9%0.018% 2/13/2025 XTX Topco Ltd7,062$446K0.0%+30.9%0.022% 2/12/2025 JPMorgan Chase & Co.14,636$924K0.0%+130.3%0.047% 1/28/2025 Advisors Preferred LLC798$52K0.0%N/A0.003% 1/3/2025 GAMMA Investing LLC1,290$81K0.0%+48.1%0.004% 12/26/2024 JPMorgan Chase & Co.6,356$298K0.0%+7,122.7%0.021% 11/15/2024 XTX Topco Ltd5,394$253K0.0%N/A0.018% 11/15/2024 State Street Corp20,086$942K0.0%+28.2%0.066% 11/15/2024 Point72 Asset Management L.P.4,800$225K0.0%-34.3%0.016% 10/7/2024 GAMMA Investing LLC871$41K0.0%+103.5%0.003% 8/19/2024 Point72 Asset Management L.P.7,311$334K0.0%-16.0%0.025% 8/15/2024 Armistice Capital LLC148,000$6.76M0.1%N/A0.497% 2/13/2024 Armistice Capital LLC36,000$1.65M0.0%N/A0.130% 2/7/2024 Jump Financial LLC5,200$238K0.0%N/A0.019% 11/8/2023 Atria Wealth Solutions Inc.74,019$2.36M0.0%-90.9%0.272% 8/3/2023 Atria Wealth Solutions Inc.814,498$11.64M0.2%+0.3%3.268% 2/13/2023 Atria Wealth Solutions Inc.811,765$24.47M0.4%+1,397.6%3.264% 11/3/2022 Barclays PLC6,661$223K0.0%N/A0.027% 8/15/2022 Atria Wealth Solutions Inc.49,463$1.54M0.0%N/A0.199% (Data available from 1/1/2016 forward) BLTE Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of BLTE shares? During the previous two years, 17 institutional investors and hedge funds held shares of Belite Bio. The most heavily invested institutionals were Armistice Capital LLC ($6.76M), Alyeska Investment Group L.P. ($5.54M), Atria Wealth Solutions Inc. ($2.36M), State Street Corp ($942K), Marshall Wace LLP ($547K), XTX Topco Ltd ($446K), and JPMorgan Chase & Co. ($390K).Learn more on Belite Bio's institutional investors. What percentage of Belite Bio's stock is owned by institutional investors? 0.53% of Belite Bio's stock is owned by institutional investors. Learn more on BLTE's institutional investor holdings. Which institutional investors have been buying Belite Bio's stock? Of the 12 institutional investors that purchased Belite Bio's stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Armistice Capital LLC ($184K), GAMMA Investing LLC ($122.57K), Alyeska Investment Group L.P. ($83.62K), JPMorgan Chase & Co. ($14.55K), Marshall Wace LLP ($9.49K), XTX Topco Ltd ($7.06K), and BNP Paribas Financial Markets ($5.74K). How much institutional buying is happening at Belite Bio? Institutional investors have bought a total of 255,686 shares in the last 24 months. This purchase volume represents approximately $16.42M in transactions. Which of Belite Bio's major shareholders have been selling company stock? The following institutional investors have sold Belite Bio stock in the last 24 months: Bank of America Corp DE ($4.31K), Marshall Wace LLP ($2.62K), Point72 Asset Management L.P. ($2.51K), JPMorgan Chase & Co. ($1.41K), Citadel Advisors LLC ($1.25K), Virtus Investment Advisers LLC ($1.08K), and Virtus ETF Advisers LLC ($721.00). How much institutional selling is happening at Belite Bio? Institutional investors have sold a total of 14,160 shares in the last 24 months. This volume of shares sold represents approximately $814.65K in transactions. Related Companies BPMC Major Shareholders ELAN Major Shareholders ROIV Major Shareholders GRFS Major Shareholders LEGN Major Shareholders RVMD Major Shareholders RYTM Major Shareholders RNA Major Shareholders NUVL Major Shareholders ABVX Major Shareholders This page (NASDAQ:BLTE) was last updated on 8/22/2025 by MarketBeat.com Staff From Our Partners[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredSilver’s Still Under $35… For Now.Silver is trading around $33—but insiders are betting on a $70 breakout by year’s end. With supply shrinkin...GoldenCrest Metals | SponsoredI trusted Trump and got screwedPorter Stansberry says he got one thing wrong—and now millions of Americans could pay the price. After warning...Porter & Company | SponsoredWhat Steve Bannon revealed about Trump’s gold playA Trump advisor just said 3 words that could reset the dollar. It’s a gold move nobody saw coming—and your ...Reagan Gold Group | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredUS attacks China, September 30?The White House just ordered more than 400 government agencies to prepare for the next phase of America’s econ...Stansberry Research | SponsoredOne tiny company just cracked Google’s $19B problemGoogle’s AI-powered search could cost $20 billion a year in electricity—nearly half its profits. But new resea...True Market Insiders | SponsoredElon Musk’s New TechnologyElon Musk is building something in Memphis that could eclipse even Tesla and SpaceX. At the heart of it is a n...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Belite Bio, Inc. Sponsored ADR Please log in to your account or sign up in order to add this asset to your watchlist. Share Belite Bio With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access